Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 496-507

  Mandal, Swati ^a   Maharjan, Mahendra ^a   Singh, Sarman ^b   Chatterjee, Mitali ^c   Madhubala, Rentala ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antimony resistance; AQP1; Biomarker; Indian isolates

Indexed keywords

ANTIMONY GLUCONATE; AQUAGLYCEROPORIN; ARGININE; COMPLEMENTARY DNA; GLUTAMIC ACID; METAL; RNA;

AMASTIGOTE; ANTIMONY RESISTANCE; ANTIMONY SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA DONOVANI; METAL BINDING; MOLECULAR CLONING; NONHUMAN; POSTKALAAZAR SKIN LEISHMANIASIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKIN LEISHMANIASIS; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

AMINO ACID SEQUENCE; ANTIMONY; ANTIPROTOZOAL AGENTS; AQUAPORIN 1; DNA, PROTOZOAN; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENES, PROTOZOAN; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PARASITIC SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

EID: 77950336943     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp468     Document Type: Article

References (38)

1. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992; 86: 355-9.
2. Zijlstra EE, Musa AM, Khalil EA et al. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003; 3: 87-98.
3. Sundar S, More DK, Singh MK et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000; 31: 1104-7.
4. Hadighi R, Mohebali M, Boucher P et al. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 2006; 3: e162.
5. Lira R, Sundar S, Makharia A et al. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 1999; 180: 564-7.
6. Rojas R, Valderrama L, Valderrama M et al. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis 2006; 193: 1375-83.
7. Mukherjee A, Padmanabhan PK, Singh S et al. Role of ABC transporter MRPA, g-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 2007; 59: 204-11.
8. Haimeur A, Brochu C, Genest P et al. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Mol Biochem Parasitol 2000; 108: 131-5.
9. Legare D, Papadopoulou B, Roy G et al. Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp Parasitol 1997; 87: 275-82.
10. Mukhopadhyay R, Dey S, Xu N et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc Natl Acad Sci USA 1996; 93: 10383-7.
11. Gourbal B, Sonuc N, Bhattacharjee H et al. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 2004; 279: 31010-7.
12. Richard D, Leprohon P, Drummelsmith J et al. Growth phase regulation of the main folate transporter of Leishmania infantum and its role in methotrexate resistance. J Biol Chem 2004; 279: 54494-501.
13. Marquis N, Gourbal B, Rosen BP et al. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol 2005; 57: 1690-9.
14. Uzcategui NL, Zhou Y, Figarella K et al. Alteration in glycerol and metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin LmAQP1. Mol Microbiol 2008; 70: 1477-86.
15. Dey A, Singh S. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India. Infect Genet Evol 2007; 7: 219-22.
16. Mandal S, Maharjan M, Ganguly S et al. High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric b-lactamase assay. Indian J Exp Biol 2009; 47: 475-9.
17. Buckner FS, Wilson AJ. Colorimetric assay for screening compounds against Leishmania amastigotes grown in macrophages. Am J Trop Med Hyg 2005; 72: 600-5.
18. Dutta A, Bandyopadhyay S, Mandal C et al. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol Int 2005; 54: 119-22.
19. Shaked-Mishan P, Ulrich N, Ephros M et al. Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem 2001; 276: 3971-6.
20. Bellofatto V, Cross GA. Expression of a bacterial gene in a trypanosomatid protozoan. Science 1989; 244: 1167-9.
21. El Tai NO, El Fari M, Mauricio I et al. Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Exp Parasitol 2001; 97: 35-44.
22. Decuypere S, Rijal S, Yardley V et al. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 2005; 49: 4616-21.
23. Maharjan M, Singh S, Chatterjee M et al. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. Am J Trop Med Hyg 2008; 79: 69-75.
24. Perez-Victoria FJ, Gamarro F, Ouellette M et al. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J Biol Chem 2003; 278: 49965-71.
25. Vasudevan G, Ullman B, Landfear SM. Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity. Proc Natl Acad Sci USA 2001; 98: 6092-7.
26. Jung JS, Preston GM, Smith BL et al. Molecular structure of the water channel through aquaporin CHIP. The hourglass model. J Biol Chem 1994; 269: 14648-54.
27. Zardoya R. Phylogeny and evolution of the major intrinsic protein family. Biol Cell 2005; 97: 397-414.
28. Sereno D, Cavaleyra M, Zemzoumi K et al. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother 1998; 42: 3097-102.
29. Fairlamb AH, Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 1992; 46: 695-729.
30. Haimeur A, Guimond C, Pilote S et al. Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol 1999; 34: 726-35.
31. Legare D, Richard D, Mukhopadhyay R et al. The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 2001; 276: 26301-7.
32. Sreenivas G, Raju BV, Singh R et al. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans. J Clin Microbiol 2004; 42: 1739-41.
33. Croft SL. PKDL-a drug related phenomenon? Indian J Med Res 2008; 128:10-1.
34. Thakur CP, Kumar A, Mitra G et al. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 2008; 128: 38-44.
35. Saha S, Mondal S, Ravindran R et al. IL-10- and TGF-b-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 2007; 179: 5592-603.
36. Beitz E. Aquaporins from pathogenic protozoan parasites: structure, function and potential for chemotherapy. Biol Cell 2005; 97: 373-83.
37. Callahan HL, Roberts WL, Rainey PM et al. The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux. Mol Biochem Parasitol 1994; 68: 145-9.
38. Dey S, Ouellette M, Lightbody J et al. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc Natl Acad Sci USA 1996; 93: 2192-7.